Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns

Camilia R Martin1, Melissa Bellomy, Elizabeth N Allred

  • 1Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA, USA. cmartin1@bidmc.harvard.edu

Insights

Systemic inflammation markers like CRP and IL-6 are elevated in preterm infants with necrotizing enterocolitis (NEC) and intestinal perforation (IP). Understanding these inflammatory responses may aid in preventing and treating these serious infant conditions.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Immunology

Background:

  • Infants born prematurely, especially before 28 weeks gestation, are at high risk for serious gastrointestinal complications.
  • Necrotizing enterocolitis (NEC) and intestinal perforation (IP) are critical conditions in preterm neonates, often linked to inflammatory processes.
  • The precise role of systemic inflammation in the pathogenesis of NEC and IP requires further elucidation.

Purpose of the Study:

  • To investigate the profile of systemic inflammation in preterm infants diagnosed with intestinal perforation (IP) and necrotizing enterocolitis (NEC).
  • To identify specific blood protein biomarkers associated with the presence and progression of IP and NEC in very preterm infants.

Main Methods:

  • A cohort of 939 infants born before 28 weeks' gestation was studied.
  • Blood samples were collected on days 1, 7, and 14 postpartum.
  • Concentrations of 25 blood proteins, including inflammatory markers, were measured using quantitative assays.

Main Results:

  • Infants with NEC showed elevated levels of C-reactive protein (CRP), serum amyloid A (SAA), IL-6, and IL-8 on days 7 and 14.
  • Infants with IP exhibited elevated CRP and insulin growth factor binding protein-1 on day 7.
  • On day 14, infants with IP had increased levels of CRP, SAA, TNF-receptor-2, and matrix metalloproteinase-9.

Conclusions:

  • Systemic inflammation plays a significant role in the pathophysiology of both NEC and IP in very preterm infants.
  • Specific inflammatory markers differ between NEC and IP, suggesting distinct inflammatory pathways.
  • Further understanding of these systemic inflammatory responses could lead to improved diagnostic tools and therapeutic strategies for these conditions.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...